According to two sources on the matter, the U.S. Food and Drug Administration employee was fired over the weekend Neuralink, a brain implant company in Elon Musk, as part of the broader federal workforce.
SOPA Images | lightrocket | Getty Images
The U.S. Food and Drug Administration is asking some recently fired scientists if they will return to work, including some employee reviews Elon Musk’s According to multiple sources familiar with the matter, brain plant implant company Neuralink.
According to President Donald Trump’s busy schedule last week, the FDA plans to rehire about 300 people. Reuters was unable to verify the number.
Elon Musk, the richest man in the world, was in charge of Neuralink and spent more than $250 million to help elect Trump, and he has been working to lay off employees with government efficiency. Thousands of people were cut.
At least 11 employees working at the FDA Equipment and Radiation Health Center (responsible for Medical Equipment Reviews) have received calls since Friday saying they can return to work on Monday. Some sources have been told that the FDA will continue to return throughout the weekend.
If scientists agree to return, they fired less than a third of their staff about a week ago. The White House told Reuters that the government has fired more than 1,000 FDA employees.
According to Reuters, the FDA fire last week included about 20 people in its office of Neurological and Physical Medical Equipment, some of whom worked on neurofusion. It is unclear whether all the fired workers reviewing Neuralink received a return offer.
Reuters reported in 2023 that the FDA initially rejected Neuralink’s request to start a clinical trial, citing safety risks. The agency has since received initiation approval for clinical trials, which is in progress.
The FDA did not immediately respond to a request for comment. The White House declined to comment and forwarded the question to the federal health department that had no response.
carnival
The attempts to return to the FDA scientists follow the Trump administration’s rebirth, which includes some employees in charge of U.S. nuclear weapons and scientists engaged in worsening bird flu outbreaks.
Several scientists who received the FDA call said they were not sure whether to return, although three said they would.
They told Reuters that they chose to work at the FDA because they believe in the public health and security mission and usually give up on the private sector’s salary is much higher.
“I know (Trump administration officials) are trying to do Silicon Valley operations, break into things, break things, break things,” said a scientist who received the call. “But how do you go about when you don’t offer Silicon Valley stocks or payments,” he said. Hire good people and you have canceled their stability?”
Americans need “an effective, effective FDA review process that helps advance medical technology for American patients. Bringing these specific experts back will help achieve this task.” Shooting.
Hundreds of jobs are funded by medical device companies, banks and others rather than taxpayers’ fees, which raises questions about the Trump administration’s stated goal of saving taxpayer currency.
At least three employees requested a re-joining FDA to receive a termination letter informing their performance “is insufficient to justify further employment at the institution.” Reuters reported earlier that many of the fired employees had won the model rankings a few weeks ago with no performance issues.
White House Deputy Secretary Anna Kelly had previously told Reuters that Trump had acted quickly to cut wasted spending and non-critical government work.
